Precise Treatment System of Biliary Malignancies Based on Special Disease Database

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Unknown

Conditions

Gall Bladder Carcinoma
Biliary System Disorder
Cholangiocarcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT03499782
XHEC-JDYXY-2018-002

Details and patient eligibility

About

Malignant tumors of biliary system lack standard treatment and precise prognosis assessment methods. This study including 12 hospitals, collecting clinical and follow-up data of patients with biliary malignant tumors including cholangiocarcinoma and gallbladder carcinoma in recent 10 years, aim to build a special disease database, then use Bayesian networks and importance theory to establish a mathematical model to assess treatment strategies and prognosis accurately. At the same time, data on biliary malignant tumors newly treated by multicenters from 2018 to 2020 will be included to validate, adjust and refine the models to guide clinical individualized precise treatment.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Clinical diagnosis of biliary malignancy including gallbladder carcinoma or cholangiocarcinoma verified by pathological results
  • Must be able to undergo surgery
  • Undergoing radical surgery for biliary malignancy (R0 or R1 resection)
  • Not complicated with other malignancy
  • No other treatments before and during surgery, such as radiotherapy and chemotherapy.

Exclusion Criteria:

  • Non-primary gallbladder or cholangiocarcinoma
  • With distant metastasis (M1 phase)
  • Incomplete follow-up data
  • Died within 30 days after surgery.

Trial contacts and locations

1

Loading...

Central trial contact

Miaoyan Wei, MD,PhD; Zhaohui Tang, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems